mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |